Ingevity (NYSE:NGVT) Stock Rating Upgraded by Wall Street Zen

Key Points

• Wall Street Zen upgraded Ingevity from a “hold” to a “strong-buy,” adding to a mixed analyst picture that still leaves the stock with an overall consensus rating of “hold.”
• Ingevity beat earnings expectations in its latest quarter, reporting $1.15 EPS versus $0.84 expected and revenue of $258 million, while also raising its FY2026 guidance to 4.7–5.2 EPS.
• The stock has risen near its 52-week high, opening at $75.73 versus a low of $39.74 and a high of $79.29, with institutional investors owning about 91.6% of shares.

Ingevity (NYSE:NGVT - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "strong-buy" rating in a research report issued to clients and investors on Saturday.

NGVT has been the topic of several other research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of Ingevity in a report on Tuesday, April 21st. BMO Capital Markets reiterated an "outperform" rating and issued a $83.00 price target on shares of Ingevity in a report on Monday, March 2nd. Wells Fargo & Company raised their price target on Ingevity from $65.00 to $75.00 and gave the company an "equal weight" rating in a report on Friday, February 27th. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a $82.00 price target on shares of Ingevity in a report on Thursday, February 26th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Ingevity has a consensus rating of "Hold" and an average target price of $80.00.

Ingevity Stock Performance

Shares of NYSE:NGVT opened at $75.73 on Friday. Ingevity has a twelve month low of $39.74 and a twelve month high of $79.29. The firm has a market cap of $2.67 billion, a PE ratio of -21.33 and a beta of 1.24. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.79 and a current ratio of 1.42. The business has a fifty day moving average of $71.20 and a 200-day moving average of $64.15.

Ingevity (NYSE:NGVT - Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.31. The company had revenue of $258.00 million during the quarter, compared to analyst estimates of $254.73 million. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The firm's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period last year, the company posted $1.01 earnings per share. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, equities research analysts predict that Ingevity will post 5.05 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Global Retirement Partners LLC acquired a new position in shares of Ingevity during the 4th quarter worth approximately $27,000. Oakworth Capital Inc. acquired a new position in shares of Ingevity during the 3rd quarter worth approximately $28,000. Meeder Asset Management Inc. acquired a new position in shares of Ingevity during the 4th quarter worth approximately $33,000. Kestra Advisory Services LLC acquired a new position in shares of Ingevity during the 4th quarter worth approximately $47,000. Finally, Geneos Wealth Management Inc. increased its position in shares of Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company's stock worth $36,000 after purchasing an additional 387 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company's stock.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.